Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design

By  

International Psychogeriatrics, Vol. 27, Iss. 2, 2015-02 ,pp. : 181-197

Cambridge University Press

Access to resources Recommend Favorite

Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial

By  

International Psychogeriatrics, Vol. 20, Iss. 5, 2008-10 ,pp. : 952-963

Cambridge University Press

Access to resources Recommend Favorite

Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

By  

International Psychogeriatrics, Vol. 25, Iss. 5, 2013-05 ,pp. : 707-719

Cambridge University Press

Access to resources Recommend Favorite

Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease

By  

International Psychogeriatrics, Vol. 23, Iss. 9, 2011-11 ,pp. : 1376-1385

Cambridge University Press

Access to resources Recommend Favorite

The role of sampling in clinical trial design

By Krause Merton   Lutz Wolfgang   Boehnke Jan  

Psychotherapy Research, Vol. 21, Iss. 3, 2011-05 ,pp. : 243-251

Routledge Ltd

Access to resources Recommend Favorite